Jason W. Botten

Celdara Medical, LLC

NIH Rank #7735
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#7,735
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.6M across 2 grants · National rank #7735.

Top grants by award amount

Jason W. Botten's NIH grant portfolio, ranked by award amount.

  • 5R42AI132047-04R42
    A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome
    $993.9K
    award amount
  • 5R01AI171408-03R01
    The role of mammarenavirus defective interfering particles in protecting host fitness and the host-driven post-translational modifications that regulate their formation and function
    $613.6K
    award amount

Affiliations

Institutions that have administered grants for Jason W. Botten.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Celdara Medical, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7735
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Jason W. Botten.